Figure 2.

Expression of M1-type polarization markers with Cx43 inhibitors. (A–B) The location and expression levels of CD86 in RAW264.7 macrophages pretreated with Gap19 and Gap26 in the control, LPS, LPS + Gap19, and LPS + Gap26 groups (n = 3). (C–D) Flow cytometry was used to detect the expression frequency of CD86 in RAW264.7 macrophages pretreated with Gap19 and Gap26 (n = 3). Data are presented as the mean ± SEM (n = 3). ^*P < .05 vs control groups; ^#P < .05 vs LPS groups. Cx43 = connexin 43, LPS = lipopolysaccharide, PE = phycoerythrin.